LENZ
Price
$28.41
Change
+$1.18 (+4.33%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
852.03M
Intraday BUY SELL Signals
MLTX
Price
$13.55
Change
+$0.15 (+1.12%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
950.06M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs MLTX

Header iconLENZ vs MLTX Comparison
Open Charts LENZ vs MLTXBanner chart's image
LENZ Therapeutics
Price$28.41
Change+$1.18 (+4.33%)
Volume$18.31K
Capitalization852.03M
MoonLake Immunotherapeutics
Price$13.55
Change+$0.15 (+1.12%)
Volume$30.14K
Capitalization950.06M
LENZ vs MLTX Comparison Chart in %
LENZ
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LENZ vs. MLTX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (LENZ: $27.23 vs. MLTX: $13.41)
Brand notoriety: LENZ and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 94% vs. MLTX: 54%
Market capitalization -- LENZ: $888.64M vs. MLTX: $959.98M
LENZ [@Biotechnology] is valued at $888.64M. MLTX’s [@Biotechnology] market capitalization is $959.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MLTX is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • LENZ’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than LENZ.

Price Growth

LENZ (@Biotechnology) experienced а +2.95% price change this week, while MLTX (@Biotechnology) price change was +14.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($950M) has a higher market cap than LENZ($852M). LENZ YTD gains are higher at: -5.681 vs. MLTX (-75.235). LENZ has higher annual earnings (EBITDA): -61.87M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. LENZ (210M). LENZ has less debt than MLTX: LENZ (1.05M) vs MLTX (75.8M). LENZ has higher revenues than MLTX: LENZ (5M) vs MLTX (0).
LENZMLTXLENZ / MLTX
Capitalization852M950M90%
EBITDA-61.87M-196.98M31%
Gain YTD-5.681-75.2358%
P/E Ratio48.03N/A-
Revenue5M0-
Total Cash210M425M49%
Total Debt1.05M75.8M1%
TECHNICAL ANALYSIS
Technical Analysis
LENZMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
82%
Bearish Trend 22 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNMCX15.810.02
+0.13%
Janus Henderson Mid Cap Value D
LMSAX39.00N/A
N/A
ClearBridge Small Cap A
HSAFX9.81N/A
N/A
Hussman Strategic Allocation
DOPIX32.42N/A
N/A
BNY Mellon Opportunistic Small Cap I
WLGYX40.22-0.49
-1.20%
Macquarie Large Cap Growth Fund Y

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BHVN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+5.95%
BHVN - LENZ
43%
Loosely correlated
+14.27%
KRYS - LENZ
38%
Loosely correlated
-1.69%
ACLX - LENZ
37%
Loosely correlated
-0.49%
MLTX - LENZ
37%
Loosely correlated
+3.23%
CELC - LENZ
36%
Loosely correlated
-0.67%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+3.23%
KALA - MLTX
88%
Closely correlated
-1.46%
IOBT - MLTX
76%
Closely correlated
+25.10%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
+2.62%
NUVL - MLTX
48%
Loosely correlated
-3.48%
More